COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022

被引：14
|
作者：
Kislaya, Irina [1 ,2 ]
Machado, Ausenda [1 ,2 ]
Magalhaes, Sarah
Rodrigues, Ana Paula
Franco, Rafael
Leitek, Pedro Pinto [3 ,4 ]
Dias, Carlos Matias [1 ,2 ]
Nunes, Baltazar [1 ,2 ]
机构：
[1] Inst Nacl Sailde Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal
[2] Univ NOVA Lisboa, Ctr Invest Saude Publ, Escola Nacl Saude Publ, Lisbon, Portugal
[3] Serv Partilhados Minist Saude, Lisbon, Portugal
[4] Direcao Servi Informacao & Analise, Direcao Geral Saude, Lisbon, Portugal
来源：
EUROSURVEILLANCE | 2022年 / 27卷 / 37期
关键词：
D O I：
10.2807/1560-7917.ES.2022.27.37.2200697
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in elderly people in Portugal between May and July 2022. In 2 80 year -olds, the second booster dose VE was 81% (95% CI: 75-85) and 82% (95% CI: 77-85), respectively, against COVID-19-related hospitalisation and death. The first booster dose VE was 63% (95% CI: 55-70) in 2 80 year -olds and 74% (95% CI: 66-80) in 60-79 year-olds against hospitalisation, and 63% (95% CI: 57-69) and 65% (95% CI: 54-74) against death.
引用
收藏
页数：6
相关论文
共 45 条
  • [31] Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021
    Fabiani, Massimo
    Puopolo, Maria
    Filia, Antonietta
    Sacco, Chiara
    Mateo-Urdiales, Alberto
    Alegiani, Stefania Spila
    Del Manso, Martina
    D'Ancona, Fortunato
    Vescio, Fenicia
    Bressi, Marco
    Petrone, Daniele
    Spuri, Matteo
    Rota, Maria Cristina
    Massari, Marco
    Da Cas, Roberto
    Morciano, Cristina
    Stefanelli, Paola
    Bella, Antonino
    Tallon, Marco
    Proietti, Valeria
    Siddu, Andrea
    Battilomo, Serena
    Palamara, Anna Teresa
    Popoli, Patrizia
    Brusaferro, Silvio
    Rezza, Giovanni
    Riccardo, Flavia
    Ippolito, Francesca Menniti
    Pezzotti, Patrizio
    EXPERT REVIEW OF VACCINES, 2022, 21 (07) : 975 - 982
  • [32] Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
    Sentis, Alexis
    Kislaya, Irina
    Nicolay, Nathalie
    Meijerink, Hinta
    Starrfelt, Jostein
    Martinez-Baz, Ivan
    Castillas, Jesus
    Nielsen', Katrine Finderup
    Hansen', Christian Holm
    Emborg, Hanne-Dorthe
    Nardone, Anthony
    Derrough, Tarik
    Valenclano, Marta
    Nunes, Baltazar
    Monge, Susana
    Susana, Monge
    EUROSURVEILLANCE, 2022, 27 (30)
  • [33] mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021
    Nunes, Baltazar
    Rodriguesl, Ana Paula
    Kislaya, Irina
    Cruz, Camila
    Peralta-Santos, Andre
    Lima, Joao
    Leitek, Pedro Pinto
    Sequeira, Duarte
    Dias, Carlos Matias
    Machado, Ausenda
    EUROSURVEILLANCE, 2021, 26 (38)
  • [34] COVID-19 vaccine effectiveness in the paediatric population aged 5-17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022
    Soares, Patricia
    Machado, Ausenda
    Nicolay, Nathalie
    Monge, Susana
    Sacco, Chiara
    Hansen, Christian Holm
    Meijerink, Hinta
    Martinez-Baz, Ivan
    Schmitz, Susanne
    Humphreys, James
    Fabiani, Massimo
    Echeverria, Aitziber
    Alkerwi, Ala'a
    Nardone, Anthony
    Mateo-Urdiales, Alberto
    Castilla, Jesus
    Kissling, Esther
    Nunes, Baltazar
    EUROSURVEILLANCE, 2025, 30 (08)
  • [35] Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022
    Prasad, Namrata
    Derado, Gordana
    Nanduri, Srinivas Acharya
    Reses, Hannah E.
    Dubendris, Heather
    Wong, Emily
    Soe, Minn Minn
    Li, Qunna
    Dollard, Philip
    Bagchi, Suparna
    Edwards, Jonathan
    Shang, Nong
    Budnitz, Dan
    Bell, Jeneita
    Verani, Jennifer R.
    Benin, Andrea
    Link-Gelles, Ruth
    Jernigan, John
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (18): : 633 - 637
  • [36] Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021-December 2022
    Meijerink, Hinta
    Veneti, Lamprini
    Kristoffersen, Anja Brathen
    Danielsen, Anders Skyrud
    Stecher, Melanie
    Starrfelt, Jostein
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [37] Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study
    Mateo-Urdiales, Alberto
    Sacco, Chiara
    Fotakis, Emmanouil Alexandros
    Del Manso, Martina
    Bella, Antonino
    Riccardo, Flavia
    Bressi, Marco
    Rota, Maria Cristina
    Petrone, Daniele
    Siddu, Andrea
    Fedele, Giorgio
    Stefanelli, Paola
    Palamara, Anna Teresa
    Brusaferro, Silvio
    Rezza, Giovanni
    Pezzotti, Patrizio
    Fabiani, Massimo
    LANCET INFECTIOUS DISEASES, 2023, 23 (12): : 1349 - 1359
  • [38] Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023)
    Savulescu, Camelia
    Prats-Uribe, Albert
    Brolin, Kim
    Uuskula, Anneli
    Bergin, Colm
    Fleming, Catherine
    Zvirbulis, Viesturs
    Zavadska, Dace
    Szuldrzynski, Konstanty
    Gaio, Vania
    Popescu, Corneliu Petru
    Craiu, Mihai
    Cisneros, Maria
    Latorre-Millan, Miriam
    Lohur, Liis
    Mcgrath, Jonathan
    Ferguson, Lauren
    Abolina, Ilze
    Gravele, Dagne
    Machado, Ausenda
    Florescu, Simin Aysel
    Lazar, Mihaela
    Subirats, Pilar
    Cuesta, Laura Clusa
    Sui, Jacklyn
    Kenny, Claire
    Krievins, Dainis
    Barzdina, Elza Anna
    Melo, Aryse
    Kosa, Alma Gabriela
    Miron, Victor Daniel
    Munoz-Almagro, Carmen
    Milagro, Ana Maria
    Bacci, Sabrina
    Kramarz, Piotr
    Nardone, Anthony
    VACCINE, 2025, 45
  • [39] Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
    Horne, Elsie M. F.
    Hulme, William J.
    Keogh, Ruth H.
    Palmer, Tom M.
    Williamson, Elizabeth J.
    Parker, Edward P. K.
    Green, Amelia
    Walker, Venexia
    Walker, Alex J.
    Curtis, Helen
    Fisher, Louis
    MacKenna, Brian
    Croker, Richard
    Hopcroft, Lisa
    Park, Robin Y.
    Massey, Jon
    Morley, Jessica
    Mehrkar, Amir
    Bacon, Sebastian
    Evans, David
    Inglesby, Peter
    Morton, Caroline E.
    Hickman, George
    Davy, Simon
    Ward, Tom
    Dillingham, Iain
    Goldacre, Ben
    Hernan, Miguel A.
    Sterne, Jonathan A. C.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 378
  • [40] Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health records
    Kislaya, Irina
    Peralta-Santos, Andre
    Borges, Vitor
    Vieira, Luis
    Sousa, Carlos
    Ferreira, Bibiana
    Pelerito, Ana
    Gomes, Joao Paulo
    Leite, Pedro Pinto
    Nunes, Baltazar
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (03)
12345